FDA 483 - The Children's Hospital Corporation - February 14, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Boston Children's Hospital's Blood Bank identified three observations related to failures in following written standard operating procedures for blood and blood component collection. These failures included inadequate donor health history screening for travel-related risks, not checking deferral lists, and incomplete documentation for platelet apheresis donors. The observations indicate a lack of adherence to established protocols for ensuring donor eligibility.
ID · 76af6f61-f663-4a71-bacb-7f727fe41b60